Breaking Dawn - Part 2 Sweeps the Razzies









02/23/2013 at 10:00 PM EST







Taylor Lautner and Mackenzie Foy, in Breaking Dawn – Part 2


Andrew Cooper, SMPSP/Summit


Who's misérable now?

The Twilight Saga: Breaking Dawn – Part 2, Adam Sandler and Rihanna are among the "winners" of the 33rd annual Golden Raspberry Awards – the Razzies – which are not so much handed out as they are thrown at those who are voted as perpetrating Hollywood's worst achievements of the year.

Breaking Dawn – Part 2, the fifth and final installment in Stephenie Meyer's vampire saga, was recognized in seven categories, including worst picture.

The flick's Kristen Stewart was also cited as worst actress; Taylor Lautner, worst supporting actor; Lautner and 12-year-old Mackenzie Foy, worst screen couple; the entire cast, including Robert Pattinson, worst screen ensemble, and Bill Condon, worst director.

In addition, the film, which since opening last November has taken in more than $828 million at the box office, was named worst sequel.

Sandler, who last year monopolized the Razzies – and set a record by winning in 10 categories with the "comedy" Jack & Jill – this year got only two awards: for worst actor of the year and worst screenplay, both for That's My Boy.

Unlike the Oscars, which keep voting tallies a secret and will be handed out Sunday night during a very glamorous event, founder and Head RAZZberry John Wilson announced Razzie recipients Saturday night in the utilitarian Continental Breakfast Room of the Holiday Inn Express Hollywood Walk of Fame hotel, near (and yet so far from) the Dolby Theatre, home of the Academy Awards.

Wilson revealed to the press that although Rihanna, as worst supporting actress in the movie Battleship, won her Razzie by a landslide, worst screenwriter Sandler only beat the authors of Breaking Dawn by a single vote.

It's close shaves like that that really make or break the Razzies.

Breaking Dawn – Part 2 Sweeps the Razzies| Oscars 2013, The Razzies 2013, Movies, Battleship, That's My Boy, News Franchises, Individual Class, Adam Sandler, Kristen Stewart, Rihanna, Robert Pattinson

Adam Sandler, in That's My Boy, and Rihanna, in Battleship

Columbia; Universal

The 85th annual Academy Awards will air live on ABC starting at 7 p.m. ET/4 p.m. PT on Sunday, Feb. 24, from the Dolby Theatre in Hollywood.
Read More..

FDA approves new targeted breast cancer drug


WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.


The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent dose of anti-tumor poison.


Cancer researchers say the drug is an important step forward because it delivers more medication while reducing the unpleasant side effects of chemotherapy.


"This antibody goes seeking out the tumor cells, gets internalized and then explodes them from within. So it's very kind and gentle on the patients — there's no hair loss, no nausea, no vomiting," said Dr. Melody Cobleigh of Rush University Medical Center. "It's a revolutionary way of treating cancer."


Cobleigh helped conduct the key studies of the drug at the Chicago facility.


The FDA approved the new treatment for about 20 percent of breast cancer patients with a form of the disease that is typically more aggressive and less responsive to hormone therapy. These patients have tumors that overproduce a protein known as HER-2. Breast cancer is the second most deadly form of cancer in U.S. women, and is expected to kill more than 39,000 Americans this year, according to the National Cancer Institute.


The approval will help Roche's Genentech unit build on the blockbuster success of Herceptin, which has long dominated the breast cancer marketplace. The drug had sales of roughly $6 billion last year.


Genentech said Friday that Kadcyla will cost $9,800 per month, compared to $4,500 per month for regular Herceptin. The company estimates a full course of Kadcyla, about nine months of medicine, will cost $94,000.


FDA scientists said they approved the drug based on company studies showing Kadcyla delayed the progression of breast cancer by several months. Researchers reported last year that patients treated with the drug lived 9.6 months before death or the spread of their disease, compared with a little more than six months for patients treated with two other standard drugs, Tykerb and Xeloda.


Overall, patients taking Kadcyla lived about 2.6 years, compared with 2 years for patients taking the other drugs.


FDA specifically approved the drug for patients with advanced breast cancer who have already been treated with Herceptin and taxane, a widely used chemotherapy drug. Doctors are not required to follow FDA prescribing guidelines, and cancer researchers say the drug could have great potential in patients with earlier forms of breast cancer


Kadcyla will carry a boxed warning, the most severe type, alerting doctors and patients that the drug can cause liver toxicity, heart problems and potentially death. The drug can also cause severe birth defects and should not be used by pregnant women.


Kadcyla was developed by South San Francisco-based Genentech using drug-binding technology licensed from Waltham, Mass.-based ImmunoGen. The company developed the chemical that keeps the drug cocktail together and is scheduled to receive a $10.5 million payment from Genentech on the FDA decision. The company will also receive additional royalties on the drug's sales.


Shares of ImmunoGen Inc. rose 2 cents to $14.32 in afternoon trading. The stock has ttraded in a 52-wek range of $10.85 to $18.10.


Read More..

Digital billboard company issues $100-million threat against L.A.









An outdoor advertising company fighting to preserve dozens of digital billboards across Los Angeles warned this week that it would seek "substantially" more than $100 million from City Hall if it is ordered to remove any electronic signs targeted in a recent court ruling.


In an 11-page letter sent Friday, Clear Channel Outdoor told Mayor Antonio Villaraigosa, City Atty. Carmen Trutanich and Council President Herb Wesson that its digital signs are "valuable assets that the city cannot attempt to take away without paying just compensation."


The letter comes two months after a three-judge panel struck down a 2006 legal settlement approved by the City Council allowing Clear Channel and CBS Outdoor to convert 840 existing billboards to digital formats. The company installed 79 digital signs before the settlement was blocked.








The 2nd District Court of Appeal ordered a lower court to invalidate all digital conversions permitted under the agreement. But Sara Lee Keller, Clear Channel's lawyer, warned that if the council instructs the company to turn off the signs, "it would be exposed to liability to Clear Channel for the fair market value of such signs, which substantially exceeds $100 million."


"While litigating these claims would be costly and time-consuming for all … we believe it is important to be clear about the consequences," wrote Keller, who contends that other factors make all of the company's signs legal.


The letter drew a sharp response from Summit Media, a competing sign company that successfully sued to block the 2006 agreement. Phil Recht, the company's attorney, said Clear Channel has "no regard for the rule of law."


"Clear Channel is trying to bully the city into submission so that they can continue to make hundreds of millions of dollars in illegal profits from these digital billboards two courts ruled to be illegal," he said.


Clear Channel sent its letter one day before neighborhood activists and outdoor-advertising lobbyists — including the company and its representatives — took part in a working group to discuss possible digital sign legislation. One proposal up for discussion would allow new digital billboards to be installed in exchange for removing a greater number of static billboards.


Summit promised to work with neighborhoods on digital sign issues, saying the technology diminishes quality of life. In recent years, it has described the original 2006 agreement as a "sweetheart deal" that gave CBS and Clear Channel hundreds of millions of dollars in revenue.


Since the ruling, Clear Channel has been waging a publicity campaign in favor of digital billboards, putting together an advocacy group to argue on its behalf and touting support for its signs from such groups as AIDS Project Los Angeles, Art Share L.A. and the Los Angeles Area Chamber of Commerce. Those groups, among others, have asked the state Supreme Court to take another look at the ruling that invalidated the 2006 digital sign pact, according to Clear Channel's letter.


Clear Channel and a handful of other billboard companies also have been contributing tens of thousands of dollars in recent weeks to Proposition A, which is on the March 5 ballot and would raise the sales tax rate to 9.5% from 9%. That measure, if passed, is expected to generate more than $200 million annually for the city budget.


Meanwhile, Lamar Advertising, which has proposed its own plan for converting signs to digital formats, has been spending $5,000 per candidate on outdoor advertising promoting the City Council campaigns of Councilman Joe Buscaino, Assemblymen Bob Blumenfield (D-Woodland Hills) and Gil Cedillo (D-Los Angeles), and former Assemblyman Felipe Fuentes, as well as the city controller campaign of Councilman Dennis Zine.


Friday's letter from Clear Channel was accompanied by a legal claim, a document submitted before the filing of a lawsuit. Clear Channel spokesman Jim Cullinan said his company sent it because it must provide 90 days' notice before filing an action in court.


"This letter gives notice, but we hope it doesn't come to litigation," he said.


david.zahniser@latimes.com





Read More..

Russians Demand Return of Brother of Dead Adopted Boy in Texas





MOSCOW — Russian lawmakers on Friday demanded the return of a 2-year-old boy whose 3-year-old brother, adopted by the same family in Texas, died under murky circumstances in January, prompting allegations of abuse and an investigation.




The younger boy, Kristopher Shatto, who was born Kirill Kuzmin in Russia, remains in the custody of his adoptive parents, Alan and Laura Shatto, in Gardendale, Tex. His biological mother, Yulia V. Kuzmina, who lost custody of the boys because of alcohol addiction, has also demanded Kirill’s return.


But even as the State Duma, the lower house of Parliament, adopted a resolution calling for Kirill to be brought back to Russia, news outlets here reported that Ms. Kuzmina and her boyfriend had gotten into a drunken brawl and were removed from a train by the police while returning to Gdov, a town near the border with Estonia. They had been in Moscow for a television appearance.


Yevgeny Usovich, the owner of a resort on Lake Peipus where Ms. Kuzmina’s boyfriend, Vladimir Antipenko, worked as a bathhouse attendant, said he had seen the couple after their return but was unable to get details of their travel. “It was useless; they were drunk,” Mr. Usovich said in a telephone interview. “What could I find from them?”


In an interview with the Interfax news agency, Mr. Usovich said employees at the Ustye Beach Resort, where Mr. Antipenko worked, were shocked by the television appearance. “The staff here at the club were outraged as they were watching yesterday’s television program,” Mr. Usovich said. “And all of them said the child must not be handed back over to this couple.”


The older boy, Max Shatto, who was born Maksim Kuzmin, died on Jan. 21, and news of his death set off a huge outcry this week in Russia, which late last year banned adoptions by American citizens. Texas child welfare officials said they had received a report of abuse on the same day that Max died.


On Thursday, Shirley Standefer, chief investigator for the Ector County Medical Examiner’s Office in Texas, said bruises were found on Max’s lower abdomen. An autopsy was conducted on Jan. 23, and it normally takes 8 to 12 weeks to get results, she said. The chief medical examiner will then rule on the cause of death, she added, possibly early next week.


Russia’s child rights commissioner, Pavel A. Astakhov, who had said he would help Ms. Kuzmina regain custody of Kirill, posted a statement on his Web site on Friday seeming to backtrack after the reports of her drunkenness. He said that a decision on restoring parental rights could be made only by a court and that the bigger issue was the way American courts had mishandled abuse cases involving adopted Russian children.


“I repeat once again — the final decision is made by the court only,” Mr. Astakhov said in his statement. “Unfortunately, the debate around the death of little Maksim Kuzmin does not solve the main problem — to restore justice.”


Some Russian officials quickly accused the adoptive mother, Ms. Shatto, of beating the boy to death, but they have since pulled back and said she was guilty of negligence at a minimum.


President Valdimir V. Putin’s spokesman, Dmitri S. Peskov, on Friday urged the public to wait for the forensic results. “To qualify it is a murder or as an accident is not allowed while there is still no evidence,” Mr. Peskov said on Dozhd, a television station. “In this case, I would consider it necessary to temper emotions a bit.”


Earlier in the day, the American ambassador to Russia, Michael A. McFaul, posted a statement on his blog in English and Russian calling Max’s death a “tragedy” but urging that it not be exploited. In the post, Mr. McFaul said he was “troubled” by how some Russian news outlets were portraying the United States and Americans in the context of the Shatto case.


Ms. Shatto has told investigators that she had left the boys playing outside unattended and returned to find Max lying on the ground, unresponsive. He died later that day at a hospital.


In the resolution adopted on Friday, Russian lawmakers urged American officials to regard the issue of adopted Russian children in the United States as an “emergency situation requiring immediate reaction on the part of all government branches of our states.”


Such adoption cases are now covered by a bilateral agreement between the two countries — ratified last year — that sets forth a number of requirements for oversight and cooperation. Along with the adoption ban, which took effect on Jan. 1, the Russian government announced that it would terminate the existing agreement on adoptions on Jan. 1, 2014, following a required one-year notification period.


Mr. Putin called the adoption ban an appropriate retaliation for an American law that seeks to punish Russians accused of violating human rights.


The Russian law was named for Dima Yakovlev, a 21-month-old boy who was adopted from Russia and died of heatstroke in Virginia in July 2008, after being left in a parked car for nine hours by his father, Miles Harrison. Mr. Harrison was acquitted of manslaughter charges by a judge who called the death a tragic accident.


Dozens of American families are still hoping to complete adoptions that were in process when the ban took effect. The issue has become a major source of tension in an increasingly troubled diplomatic relationship. Officials have said that Secretary of State John Kerry and the Russian foreign minister, Sergey V. Lavrov, will discuss the Shatto case among other issues at a meeting next week in Berlin.


Staci Semrad contributed reporting from Lubbock, Tex.



Read More..

Courtney Lopez: Gia Thinks Our Dog Is Having a Baby




Celebrity Baby Blog





02/22/2013 at 01:00 PM ET



Courtney Lopez: Gia Thinks Dog Having Baby
Denise Truscello/Wireimage


Mario Lopez is a man of his word.


Following a December wedding, the EXTRA host declared he and wife Courtney would get to work expanding their family immediately — and he wasn’t kidding.


In January, the couple discovered they were indeed expecting.


“Mario and I are so excited to add to our family! I found out a month ago and surprised Mario with the good news at breakfast,” Courtney tells PEOPLE.


But the proud parents aren’t the only ones gearing up for a new addition. Big sister Gia Francesca, 2, already has babies on the brain.


“Gia kind of understands that there is a baby in my belly,” Courtney notes. “She also told me our dog Julio has a baby in his belly — so who knows!”

Despite a bumpy start — “I had a rough couple of weeks when I first found out,” she shares — the mom-to-be is feeling better and already sporting quite the blossoming belly. “I am showing so much faster this time around,” she says.


And with warmer weather on the way, Courtney will be swathing her bump in floor-length frocks — but plans on forgoing a few fashion ensembles from her past.


“I love being pregnant in the summer! I live in maxi dresses,” she says. “Looking back at my first pregnancy, there are certain things that I wore and I have no idea why. I looked horrible and I won’t do that again!”


Originally from Pittsburgh, the expectant mama is thrilled to have settled down with her growing family on the West Coast. Her only wish? That her children will one day enjoy a winter wonderland.


“I don’t miss the East Coast at all — especially the humidity,” she explains. “The one thing I do want my children to experience from an early age is snow. There is nothing like being a kid playing in the snow.”


– Anya Leon


Read More..

FDA approves new targeted breast cancer drug


WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.


The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent dose of anti-tumor poison.


Cancer researchers say the drug is an important step forward because it delivers more medication while reducing the unpleasant side effects of chemotherapy.


"This antibody goes seeking out the tumor cells, gets internalized and then explodes them from within. So it's very kind and gentle on the patients — there's no hair loss, no nausea, no vomiting," said Dr. Melody Cobleigh of Rush University Medical Center. "It's a revolutionary way of treating cancer."


Cobleigh helped conduct the key studies of the drug at the Chicago facility.


The FDA approved the new treatment for about 20 percent of breast cancer patients with a form of the disease that is typically more aggressive and less responsive to hormone therapy. These patients have tumors that overproduce a protein known as HER-2. Breast cancer is the second most deadly form of cancer in U.S. women, and is expected to kill more than 39,000 Americans this year, according to the National Cancer Institute.


The approval will help Roche's Genentech unit build on the blockbuster success of Herceptin, which has long dominated the breast cancer marketplace. The drug had sales of roughly $6 billion last year.


Genentech said Friday that Kadcyla will cost $9,800 per month, compared to $4,500 per month for regular Herceptin. The company estimates a full course of Kadcyla, about nine months of medicine, will cost $94,000.


FDA scientists said they approved the drug based on company studies showing Kadcyla delayed the progression of breast cancer by several months. Researchers reported last year that patients treated with the drug lived 9.6 months before death or the spread of their disease, compared with a little more than six months for patients treated with two other standard drugs, Tykerb and Xeloda.


Overall, patients taking Kadcyla lived about 2.6 years, compared with 2 years for patients taking the other drugs.


FDA specifically approved the drug for patients with advanced breast cancer who have already been treated with Herceptin and taxane, a widely used chemotherapy drug. Doctors are not required to follow FDA prescribing guidelines, and cancer researchers say the drug could have great potential in patients with earlier forms of breast cancer


Kadcyla will carry a boxed warning, the most severe type, alerting doctors and patients that the drug can cause liver toxicity, heart problems and potentially death. The drug can also cause severe birth defects and should not be used by pregnant women.


Kadcyla was developed by South San Francisco-based Genentech using drug-binding technology licensed from Waltham, Mass.-based ImmunoGen. The company developed the chemical that keeps the drug cocktail together and is scheduled to receive a $10.5 million payment from Genentech on the FDA decision. The company will also receive additional royalties on the drug's sales.


Shares of ImmunoGen Inc. rose 2 cents to $14.32 in afternoon trading. The stock has ttraded in a 52-wek range of $10.85 to $18.10.


Read More..

Councilman's preferred successor holds edge in Westside district









When Los Angeles City Councilman Bill Rosendahl decided in October to retire and focus on battling cancer, he anointed Mike Bonin, his longtime chief of staff, as his preferred successor.


The March 5 primary election now seems Bonin's to lose.


Of four candidates seeking to represent Council District 11 — which includes Brentwood, Mar Vista, Venice and Westchester — Bonin has raised the most money ($380,000, including matching funds, more than four times the amount amassed by his nearest rival). The self-avowed "progressive activist" has also received hundreds of endorsements from politicians, business and labor leaders, environmental groups and residents.








"He's smart, he's a doer, and he's solution-oriented," said Austin Beutner, a conservative businessman and former mayoral hopeful who recently held a meet-and-greet event for Bonin in Pacific Palisades. "He's not an ideologue."


Bonin's three opponents — Frederick Sutton, 28, a part-time bartender and community activist; Tina Hess, 52, a prosecutor with the city attorney's office; and Odysseus Bostick, 36, a Westchester teacher and parent — all acknowledge the financial leader's sizable edge. But they say they're fed up with pothole-riddled streets, homeless encampments and out-of-control municipal expenditures. Bonin, they say, represents a politics-as-usual bureaucracy that has turned the City Council into what Sutton calls "a merry-go-round of lifetime politicians."


Having received $87,000 in donations and matching funds, Sutton sees his immediate goal as keeping Bonin from getting the simple majority of votes needed to seal victory in March. "Once you get into a runoff," Sutton said, "suddenly everything changes."


Bonin, 45, has unveiled plans to make Los Angeles more employer-friendly (extend the Internet tax exemption for Silicon Beach companies, support tax credits and reduce red tape for film operations) and to improve residents' access to City Hall through regular community meetings and technology ("Hikes with Mike" and "Mayberry meets the iPhone")


After receiving his bachelor's degree in U.S. history at Harvard University, Bonin worked as a newspaper reporter before entering politics. The Massachusetts native moved to the Los Angeles area in the early 1990s. He lives in Mar Vista with his partner, Sean Arian, a consultant.


A Gold's Gym regular who eats mostly raw foods, Bonin sports five tattoos, including a recycling symbol on his left shoulder that serves partly "as a symbol of getting sober and taking a life that had been trash and making it productive again." After long overdoing it on drugs and alcohol, Bonin said, he has been sober for 18 years.


The diverse Westside sector he seeks to represent is rife with vocal activists and hot-button issues: congestion, transit construction, an imbalance between jobs and housing, transients and the modernization of Los Angeles International Airport. Like Rosendahl, Bonin opposes separating the northern runways but is all for updating the airport.


Bonin said his 17 years in public service have prepared him.


He first worked in city government as legislative deputy, district director and deputy chief of staff for former Councilwoman Ruth Galanter. He then became deputy chief of staff and district director for Rep. Jane Harman, who represented many 11th district neighborhoods before retiring from Congress. He has been Rosendahl's chief deputy since 2005.


Elected in 2005 and 2009, Rosendahl, 67, was favored to win a third and final term before being diagnosed with advanced cancer last summer.


Bonin said he has been inspired by his boss' spirit and resilience after months of grueling cancer treatments. "He's got the level of energy back that most of the staff finds exhausting to be around," Bonin told a group of elderly residents one recent afternoon.


Marcia Hanscom, a wetlands activist, said she endorsed Bonin after hearing his ideas for bringing government closer to the people and promoting nature in the city.


"He's got good values and instincts, and he also knows the inner workings of City Hall and its bureaucracy," she said in an email. "If he does as he says — getting and staying close to the constituents — he will not be so captured by City Hall as some think he is."


martha.groves@latimes.com


Times researcher Maloy Moore contributed to this report.





Read More..

Montevideo Journal: Uruguay’s Video Game Start-Ups Garner Attention





MONTEVIDEO, Uruguay — For a start-up that has a hit video game for the iPhone, the new loft-style offices of Ironhide Game Studio are exactly what one would expect — a newly hired staff labors feverishly on software updates not far from a pinball machine and custom-built monster arcade cabinet intended for letting off steam.




But the company, a success in the fiercely competitive field of video game development, stands out from other high-tech ventures in one respect: its unconventional location, which frequently confuses people abroad. “They politely ask, ‘Where is Uruguay?’ ” said Álvaro Azofra, one of the three founders of Ironhide, the company behind Kingdom Rush, a lucratively popular game in the United States that involves a cartoonish kingdom under attack by marauding yetis and ogres.


Squeezed between Brazil and Argentina and long dependent on commodities exports, Uruguay may be better known for its flocks of sheep and herds of cattle. But attention is now shifting to the country’s growing constellation of start-ups that are engineering video games for computers and hand-held devices.


Developers point to a variety of reasons that Uruguay has been able to compete with South America’s larger economies, whether the creativity of its engineers and commercial artists or its relatively relaxed immigration rules and extensive use of computers in schools.


“It’s ironic, because historically, this is a country that hates entrepreneurship, but not the culture of entrepreneurship,” said Gonzalo Frasca, a video game theorist whose company, Powerful Robot, has developed numerous games for clients in the United States, including Legends of Ooo, based on the Cartoon Network animated television series “Adventure Time.”


Mr. Frasca, 40, contrasted the skepticism that persists in relation to private enterprise in Uruguay’s cradle-to-grave welfare state, in which companies in sectors like telecommunications, casinos and even whiskey production remain under state control, with the country’s robust tradition of creativity in the arts and sciences.


“We still have strong schools for computer science,” said Mr. Frasca, who has a doctorate in video game studies from IT University of Copenhagen and is a pioneer in Uruguay’s game industry. “When people graduate, they realize they’re in a small country where they have no choice but to engage with the rest of the world.”


While ORT, Uruguay’s largest private university, offers one of the region’s first degrees in video game design, the relaxed atmosphere of seaside Montevideo — the Uruguayan writer Eduardo Galeano once remarked that his countrymen resembled “Argentines on Valium” — can still make it seem as if it would be an unlikely place for technology start-ups to thrive.


Other parts of Latin America are nurturing their own video game development scenes. Chile, for instance, recently drew attention when Atakama Labs, a game developer based in Santiago, was acquired by the Japanese gaming company DeNA.


Gaming studios have also emerged in São Paulo and Rio de Janeiro, Brazil’s two largest cities, but developers there complain of byzantine tax regulations and labor rules that make hiring employees costlier than in some rich industrialized countries. In Argentina, dozens of game-developing start-ups have been founded in Buenos Aires.


But while Argentina has traditionally had more companies in the industry, some of the momentum is seen shifting across the border to Uruguay as Argentine ventures struggle with abrupt changes in economic policy, including the tightening of currency controls that have complicated operations for exporters.


In Latin America and beyond, developers are seeking to mimic the success of Kingdom Rush, ranked in 2012 among the top-selling paid applications for the iPhone in the United States. In addition to Ironhide and Powerful Robot, an array of other game developers operates quietly.


Some, like Trojan Chicken, a developer of educational games in Spanish for schoolchildren, benefit from the heavy presence of the state across Uruguay’s economy, which avoided the privatization wave of neighboring Latin American countries in the 1990s.


Ingenio, a state-controlled incubator for start-ups, helped finance Trojan Chicken, which has created educational games including 1811, an adventure game set in colonial Uruguay, and D.E.D., a detective game in which players solve thefts of national heritage. The games are designed to be played on the inexpensive laptops distributed to schoolchildren across Uruguay.


Nearly all of the 300,000 children in Uruguay’s public schools now have their own computers, after the authorities here began embracing One Laptop per Child, the ambitious project aimed at bringing computing to children in the developing world, in 2006. Called the Plan Ceibal here, it is financed by public money.


Miguel Brechner, the director of the Plan Ceibal, said the initiative was already serving as a catalyst for Uruguayan content developers, notably gaming and animation studios. Describing Ceibal as a “digital equality plan,” he said that “reality has shown that kids get excited about games.”


Encompassing the video game companies, software development in Uruguay has evolved into a $600 million industry, making the country Latin America’s leader in per-capita software exports. But some here say that the industry may also be falling victim to its success, as salaries for developers rapidly climb and make it more expensive for start-ups to compete internationally.


Still, Uruguay’s immigration laws offer certain advantages in the competition for talented employees. Building on a history of attracting immigrants from Europe, engineers, animators and other foreign hires at start-ups can legally reside and work in Uruguay while their applications for work visas are being processed.


“Uruguay is a remarkably open place when it comes to attracting talent,” said Evan Henshaw-Plath, an American among the founders of the company that became Twitter. After moving to Uruguay in 2007, Mr. Henshaw-Plath founded a software development company that now has employees from countries like Poland and Ecuador.


Drawing a contrast between Uruguay and Brazil, he delights in telling a story about an American technology investor based in Japan who was about to embark on a business trip to South America aimed at finding start-ups in which to invest or to acquire outright.


Upon discovering that Brazil required Americans to go through a bureaucratic ordeal to obtain a visa, the investor canceled his trip there. Instead, he visited Uruguay, which has no such visa requirements, and eventually acquired Mr. Henshaw-Plath’s 20-person company, Cubox.


Mauricio Rabuffetti contributed reporting.



Read More..

Cirque Du Soleil Announces New Michael Jackson-Themed Show in Las Vegas















02/21/2013 at 09:15 PM EST







The logo


Courtesy Cirque du Soleil


The King of Pop will live in Vegas!

The long-rumored Cirque Du Soleil show based on the music of Michael Jackson was formally announced Thursday afternoon.

Premiering June 29 at Las Vegas's Mandalay Bay, the show, Michael Jackson ONE, will run 90 minutes and will feature more than 60 dancers and aerialists performing to Jackson's best known music.

Executives say the show will be different from the current Cirque Du Soleil show Immortal, which features Jackson's music.

Jackson friend and choreographer Jamie King said, "Everything [Jackson] does is with a childlike heart. For Michael, every day was fresh, every day was new, every day had to be bigger and better than the last one."

Tickets for the general public go on sale March 7.

Which Jackson song are you most excited to see performed in the show? Sound off in the comments below!

Read More..

APNewsBreak: Govs to hear Oregon health care plan


SALEM, Ore. (AP) — Oregon Gov. John Kitzhaber will brief other state leaders this weekend on his plan to lower Medicaid costs, touting an overhaul that President Barack Obama highlighted in his State of the Union address for its potential to lower the deficit even as health care expenses climb.


The Oregon Democrat leaves for Washington, D.C., on Friday to pitch his plan that changes the way doctors and hospitals are paid and improves health care coordination for low income residents so that treatable medical problems don't grow in severity or expense.


Kitzhaber says his goal is to win over a handful of other governors from each party.


"I think the politics have been dialed down a couple of notches, and now people are willing to sit down and talk about how we can solve the problem" of rising health care costs, Kitzhaber told The Associated Press in a recent interview.


Kitzhaber introduced the plan in 2011 in the face of a severe state budget deficit, and he's been talking for two years about expanding the initiative beyond his state. Now, it seems he's found people ready to listen.


Hospital executives from Alabama visited Oregon last month to learn about the effort. And the U.S. Department of Health and Human Services announced Thursday that it's giving Oregon a $45 million grant to help spread the changes beyond the Medicaid population and share information with other states, making it one of only six states to earn a State Innovation Model grant.


Kitzhaber will address his counterparts at a meeting of the National Governors Association. His talk isn't scheduled on the official agenda, but a spokeswoman confirmed that Kitzhaber is expected to present.


"The governors love what they call stealing from one another — taking the good ideas and the successes of their colleagues and trying to figure out how to apply that in their home state," said Matt Salo, director of the National Association of Medicaid Directors.


There's been "huge interest" among other states in Oregon's health overhaul, Salo said, not because the concepts are brand new, but because the state managed to avoid pitfalls that often block health system changes.


Kitzhaber persuaded state lawmakers to redesign the system of delivering and paying for health care under Medicaid, creating incentives for providers to coordinate patient care and prevent avoidable emergency room visits. He has long complained that the current financial incentives encourage volume over quality, driving costs up without making people healthier.


Obama, in his State of the Union address this month, suggested that changes such as Oregon's could be part of a long-term strategy to lower the federal debt by reigning in the growing cost of federally funded health care.


"We'll bring down costs by changing the way our government pays for Medicare, because our medical bills shouldn't be based on the number of tests ordered or days spent in the hospital — they should be based on the quality of care that our seniors receive," Obama said.


The Obama administration has invested in the program, putting up $1.9 billion to keep Oregon's Medicaid program afloat over the next five years while providers make the transition to new business models and incorporate new staff and technology.


In exchange, though, the state has agreed to lower per-capita health care cost inflation by 2 percentage points without affecting quality.


The Medicaid system is unique in each state, and Kitzhaber isn't suggesting that other states should adopt Oregon's specific approach, said Mike Bonetto, Kitzhaber's health care policy adviser. Rather, he wants governors to buy into the broad concept that the delivery system and payment models need to change.


That's not a new theory. But Oregon has shown that under the right circumstances massive changes to deeply entrenched business models can gain wide support.


What Oregon can't yet show is proof the idea is working — that it's lowering costs without squeezing on the quality or availability of care. The state is just finishing compiling baseline data that will be used as a basis of comparison.


One factor driving the Obama administration's interest in Oregon's success is the president's health care overhaul. Under the Affordable Care Act, millions more Americans will join the Medicaid rolls after Jan. 1, and the health care system will have to be able to absorb the influx of patients in a logistically and financially sustainable way.


The federal government will pay 100 percent of the costs for those additional patients in the first three years before scaling back to 90 percent in 2020 and beyond.


"There are a lot of governors who are facing the same challenges we're facing in Oregon," Kitzhaber said. "They recognize that the cost of health care is something they're going to have to get their arms around."


Read More..